Array BioPharma (ARRY) Reports Q1 Loss of $0.52, Beats by 3c
ARRY Hot Sheet
Financial Fact:Weighted average shares outstanding - basic (in shares): 74.82M
Today's EPS Names:
TARO, BRLI, TLB, More
Array BioPharma Inc. (NASDAQ: ARRY) reports Q1 loss of $0.52, 3 cents better than the analyst estimate of ($0.55). Revenue for the quarter was $7.9 million, which compares to the estimate of $7.52 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Infoblox (BLOX) Tops Q3 EPS by 4c; Guides Q4
- Semtech Corp (SMTC) Misses Q1 EPS by 4c; Guides Q2
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
